What changed
$TER — Tests semiconductor chips for quality and reliability.
🎯 Q1 FY26 | Rev $1B | EPS $2.56 vs $2.12 🟢 | Margin 36.9%
💡 Consensus expects a normalization after a blowout AI-driven quarter. I think the market underestimates the durability of AI-related test demand and the potential for further upside from non-AI segments recovering, but the stock already prices in a lot of good news. The 20.93% EPS beat is impressive but largely anticipated given the AI narrative.
🏢 Business Quality: 8/10 | Valuation: rich
📉 Reward/Risk: Upside 10% to $406 (consensus PT), downside 25% to $277 (mean reversion). Ratio: 0.4x, unfavorable.
🔮 Catalyst: Q2 2026 earnings report (late July): watch for Q3 guidance and non-AI test demand recovery. Metric: Q3 revenue guidance vs consensus $1.01B. Failure signal: guidance below $950M.
💰 Entry: Current price $369.21 is not attractive.
Also in play: $PWR $QUAD $ACCO $MEG $KFY